By |

Profile

Verastem Inc is a part of the healthcare sector. It is focused on discovering and developing drugs to aid patients suffering from cancer. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. The company is engaged in running clinical trials in cancers where there are limited treatment options, including lung, ovarian, lymphoma, pancreatic and other advanced cancers.

Contact Information

Website: www.verastem.com
Email: rgagnon@verastem.com
Main Phone: +1 781 292-4200
Address: 117 Kendrick Street
Address 2: Suite 500
State: MA
City / Town: Needham
Country: USA
Postal Code: 02494

Issuer Information

Exchange: NSD
CEO: Robert Forrester
Employees: 69
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Verastem Inc is a part of the healthcare sector. It is focused on discovering and developing drugs to aid patients suffering from cancer. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. The company is engaged in running clinical trials in cancers where there are limited treatment options, including lung, ovarian, lymphoma, pancreatic and other advanced cancers.

Contact Information

Website: www.verastem.com
Email: rgagnon@verastem.com
Main Phone: +1 781 292-4200
Address: 117 Kendrick Street
Address 2: Suite 500
State: MA
City / Town: Needham
Country: USA
Postal Code: 02494

Issuer Information

Exchange: NSD
CEO: Robert Forrester
Employees: 69
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 3.29 $ -0.17 (-4.91%)
Last Price 3.29 Change $ -0.17 Change % -4.91 Tick N/A
Bid 3.25 Bid Size 10,100.00 Ask 3.36 Ask Size 1,000.00
Open 3.44 High 3.44 Low 3.26 Prev Close 3.46
Last Trade Volume 2.1 mi 52 Wk Hi 10.35 52 Wk Low 2.77
Market Cap 242.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 73,791,344.00 EPS (TTM) -1.43 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 3
Number of Buys 2 3
Number of Sells 0 0
Net Activity 10700 71238
Last 10 Buys Shares
Steven H. Bloom 1,000
Joseph M. Lobacki 1,000
Timothy J. Barberich 1,000
Timothy J. Barberich 1,000
Monica Kleinman 1,000
John B. Green 1,000
Robert Forrester 1,000
John B. Green 1,000
Daniel Paterson 1,000
Robert Forrester 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 17 17 17 17
Low Target Price Estimate 7 7 7 7
Mean Target Price Estimate 13.14 13.14 13.14 13.14
Standard Deviation 3.72 3.72 3.72 3.72
Date of Most Recent Estimate 05/31/18 05/22/18 05/22/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 5 5
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.14 1.14 1.17 1.17